08-Feb-17 Smith & Nephew reported a 7 percent drop in profit, as tough conditions in China and Saudi Arabia kept growth in check. The company has focused on emerging markets in recent years to boost sluggish demand in the US and Europe, where it competes with Zimmer and Stryker. The company delivered growth, but not at the level it had wanted. [image: Smith & Nephew]

06-Feb-17 China's Vincent Medical Holdings has made a $3 million investment for a 15 percent stake in Isreal's InovyTec Medical Solutions, a company that makes medical devices for emergency medicine and trauma care. Vincent Medical Holdings, a Chinese holding company does research and development and manufacture and sale of medical devices. [image: Vincent Medical]

03-Feb-17 The Korean government will invest KRW315.7 bn (USD276 mn) to secure original technologies for bio sectors such as new drugs, medical devices, future medical care, genomics and brain science in 2017. This includes KRW263 bn for bio-medical technology development projects. This year's budget is 31% more than last year’s. [image: Business Korea]

02-Feb-17 While the healthcare sector claims to be 'satisfied' with the move to formulate new rules regarding medical devices, industry still seeks more clarity. The rules are proposed to be internationally harmonised to attract investments, and thereby reduce costs of devices. [image: Deccan Herald]

26-Jan-17 Verily, the Alphabet subsidiary formerly known as Google Life Sciences, has raised USD800 mn in funding from Temasek, the Singapore government investment company. "Proceeds may be used to support our growth in key strategic areas, including potential acquisitions, investment in partnerships and developing new opportunities on a global scale," according to a spokesperson for Verily. [image: Verily]